Aerosol dispenser cap
Latest Novartis AG Patents:
- Tricyclic AKR1C3 dependent KARS inhibitors
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins
- Solid forms comprising an oxime ether compound, compositions and methods of use thereof
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
Description
FIG. 1 is a top and rear perspective view of the aerosol dispenser cap.
FIG. 2 is a top and front perspective view of the aerosol dispenser cap.
The opposite side of the cap not shown is a mirror image of that shown.
The bottom of the cap forms no part of the claimed design.
In use, the aerosol dispenser cap is removably attached to the top of an aerosol dispenser, e.g., an aerosol can, above the nozzle, i.e., it may be removed from the dispenser without resulting in the release of the dispenser's contents.
Referenced Cited
Patent History
Patent number: D411801
Type: Grant
Filed: Jan 7, 1997
Date of Patent: Jul 6, 1999
Assignee: Novartis AG (Basel)
Inventors: J. Ross Kinneir (Bristol), Graeme L. J. Paterson (Cheddar)
Primary Examiner: James Gandy
Assistant Examiner: Cathron B. Matta
Attorney: Gabriel Lopez
Application Number: 0/64,627
Type: Grant
Filed: Jan 7, 1997
Date of Patent: Jul 6, 1999
Assignee: Novartis AG (Basel)
Inventors: J. Ross Kinneir (Bristol), Graeme L. J. Paterson (Cheddar)
Primary Examiner: James Gandy
Assistant Examiner: Cathron B. Matta
Attorney: Gabriel Lopez
Application Number: 0/64,627
Classifications
Current U.S. Class:
D/9498
International Classification: 0907;
International Classification: 0907;
